Consortium to Establish a Registry for Alzheimer's Disease (CERAD): The first twenty years

Alzheimer's and Dementia

Volumn 4, Issue 2, 2008, Pages 96-109

  Fillenbaum, Gerda G ^a,b   van Belle, Gerald ^c   Morris, John C ^d   Mohs, Richard C ^e   Mirra, Suzanne S ^f   Davis, Patricia C ^g   Tariot, Pierre N ^h   Silverman, Jeremy M ⁱ   Clark, Christopher M ^j   Welsh Bohmer, Kathleen A ^k   Heyman, Albert ^l  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Education   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ELI LILLY AND COMPANY   (United States)

^f SUNY DOWNSTATE MEDICAL CENTER   (United States)

^g Northwest Radiology Consultants   (United States)

^h UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

^k Department of Medicine   (United States)

^l DUKE UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Alzheimer's disease; CERAD; Clinical assessment; Consortium to Establish a Registry for Alzheimer's Disease; Incidence; Neuropathological assessment; Neuropsychological assessment; Norms; Prevalence

Indexed keywords

ALZHEIMER DISEASE; BEHAVIORAL RESEARCH; CAREGIVER; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL RESEARCH; CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMER DISEASE; DATA BASE; FAMILY HISTORY; HEALTH CARE NEED; HEALTH SERVICE; HUMAN; NEUROPATHOLOGY; NEUROPHYSIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REGISTRIES; SOCIETIES, SCIENTIFIC;

EID: 40649085808     PISSN: 15525260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jalz.2007.08.005     Document Type: Review

References (117)

1. Foerstl H., Howard R., Burns A., and Levy R. 'The strange mental state of an old man who thought he would be slaughtered': an early report of dementia with delusion (1785). J Royal Soc Med 84 (1991) 432-434
2. Alzheimer A. Über einer eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatrie 64 (1907) 146-148
3. Jorm A.F., and Jolley D. The incidence of dementia: a meta-analysis. Neurology 51 (1998) 728-733
4. National Center for Health Statistics. Health, United States, 2005 with chartbook on trends on the health of Americans (2005), US Government Printing Office, Hyattsville, MD
5. Freedman V.A., Martin L.G., and Schoeni R.F. Recent trends in disability and functioning among older adults in the United States: a systematic review. JAMA 288 (2002) 3137-3146
6. Manton K.G., Gu X., and Lamb V. Change in chronic disability from 1982 to 2004/2005 as measured by long-term changes in function and health in the U.S. elderly population. PNAS 103 (2006) 18374-18379
7. rd ed. (1980), American Psychiatric Association, Washington, DC
8. rd ed, revised (1987), American Psychiatric Association, Washington, DC
9. th ed. (1994), American Psychiatric Association, Washington, DC
10. nd ed. (1980), U.S. Dept of Health and Human Services, Public Health Service, Health Care Financing Administration, Washington, DC
11. World Health Organization. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research (1993), World Health Organization, Geneva
12. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS/ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
13. Khachaturian Z.S. Diagnosis of Alzheimer's disease. Arch Neurol 42 (1985) 1097-1105
14. Erkinjuntii T., Østbye T., Steenhuis R., and Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med 337 (1997) 1667-1674
15. U. S. General Accounting Office. Alzheimer's disease: estimates of prevalence in the United States (1998), GAO/HEHS 98-16, Washington, DC
16. Morris J.C., Heyman A., Mohs R.C., Hughes J.P., van Belle G., Fillenbaum G., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part 1-clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39 (1989) 1159-1165
17. Mirra S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part II-standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 (1991) 479-486
18. Davis P.C., Gray L., Albert M., Wilkinson W., Hughes J., Heyman A., et al. Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part III-reliability of a standardized MRI evaluation of Alzheimer's disease. Neurology 42 (1992) 1676-1680
19. Mack J.L., Patterson M.B., and Tariot P.N. Behavior Rating Scale for Dementia (BRSD): development of test scales and presentation of data for 555 individuals with Alzheimer's disease. J Geriatr Psych Neurol 12 (1999) 211-223
20. Tariot P., Mack J.L., Patterson M.B., Edland S.D., Weiner M.F., Fillenbaum G., et al. The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry 152 (1995) 1349-1357
21. Silverman J.M., Raiford K., Edland S., Fillenbaum G., Morris J.C., Clark C.M., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part VI-family history assessment: a multicenter study of first-degree relatives of Alzheimer's disease probands and nondemented spouse controls. Neurology 44 (1994) 1253-1259
22. Clark C.M., Ewbank D., Lerner A., Doody R., Henderson V.W., Panisset M., et al. The relationship between extrapyramidal signs and cognitive performance in patients with Alzheimer's disease enrolled in the CERAD Study. Neurology 49 (1997) 70-75
23. Folstein M.F., Folstein S.E., and McHugh P.R. 'Mini-Mental State': a practical method of grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
24. Katzman R., Brown T., Fuld P., Peck A., Schechter R., and Schimmel H. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry 140 (1983) 734-739
25. Blessed G., Tomlinson B.E., and Roth M. The association between quantitative measures of dementia and senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry 114 (1968) 797-811
26. Fillenbaum G.G., Beekly D., Edland S.D., Hughes J.P., Heyman A., and van Belle G. Consortium to Establish a Registry for Alzheimer's Disease (CERAD): development, data base structure and selected findings. Topics in Health Information Management 1 (1997) 47-58
27. Koss E., Peterson B., and Fillenbaum G.G. Determinants of attrition in a natural history study of Alzheimer's disease. Alzheimer Dis Assoc Disord 13 (1999) 209-215
28. Galasko D., Edland S.D., Morris J.C., Clark C., Mohs R., and Koss E. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part XI-clinical milestones in patients with Alzheimer's disease followed over 3 years. Neurology 45 (1995) 1451-1455
29. McDaniel K.D., Edland S.D., Heyman A., and CERAD clinical investigators. Relationship between level of insight and severity of dementia in Alzheimer disease: Consortium to Establish a Registry for Alzheimer's Disease. Alzheimer Dis Assoc Disord 9 (1995) 101-104
30. Neumann P.J., Araki S.S., Arcelus A., Longo A., Papadopoulos G., Kosik K.S., et al. Measuring Alzheimer's disease progression with transition probabilities: estimates from CERAD. Neurology 57 (2001) 957-964
31. Weiner M.F., Doody R.S., Sairam R., Foster B., and Liao T.Y. Prevalence and incidence of major depressive disorder in Alzheimer's disease: findings from two databases. Dementia & Geriatric Cog Disord 13 (2002) 8-12
32. White H., Pieper C., Schmader K., and Fillenbaum G. Weight change in Alzheimer's disease. J Am Geriatr Soc 44 (1996) 265-272
33. Borson S., Scanlan J.M., Chen P., and Ganguli M. The Mini-Cog as a screen for dementia: validation in a population-based sample. J Am Geriatr Soc 51 (2003) 1451-1454
34. Hughes C.P., Berg L., Danziger W.L., Coben L.A., and Martin R.L. A new clinical scale for the staging of dementia. Br J Psychiatry 140 (1982) 566-572
35. Barnett M. Standardization of Clinical Dementia Rating (CDR) among 23 Alzheimer's disease study centers (1992), Department of Biostatistics, University of Washington, Seattle, WA Master's thesis
36. Mirra S., Gearing M., and Nash F. Neuropathologic assessment of Alzheimer's disease. Neurology 49 Suppl.3 (1997) S14-S16
37. Welsh-Bohmer K.A., and Mohs R.C. Neuropsychological assessment of Alzheimer's disease. Neurology 49 Suppl 3 (1997) S11-S13
38. Fillenbaum G.G., Unverzagt F.W., Ganguli M., Welsh-Bohmer K.A., and Heyman A. The CERAD Neuropsychological Battery: performance of representative community and tertiary care samples of African American and European American elderly. In: Ferraro F.R. (Ed). Minority and cross-cultural aspects of neuropsychological assessment (2002), Swets and Zeitlinger, Lisse, Netherlands 45-62
39. Ganguli M., Ratcliff G., and DeKosky S.T. Cognitive test scores in community-based older adults with and without dementia. Aging & Mental Health 1 (1997) 176-180
40. Morris J.C., Edland S., Clark C., Galasko D., Koss E., Mohs R., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part IV-rates of cognitive change, a longitudinal assessment of probable Alzheimer's disease. Neurology 43 (1993) 2457-2465
41. Davis P.C., Gearing M., Gray L., Mirra S.S., Morris J.C., Edland S.D., et al. The CERAD experience, part VIII: neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease. Neurology 45 (1995) 178-179
42. Mirra S., Hart M.N., and Terry R.D. Making the diagnosis of Alzheimer's disease: a primer for practicing pathologists. Arch Pathol Lab Med 117 (1993) 132-144
43. Crain B.J., and Mirra S.S. The autopsy in cases of Alzheimer's disease and other dementias. In: Collins K.A., and Hutchins G.M. (Eds). Autopsy performance & reporting. 2nd ed. (2003), College of American Pathologists, Northfield, IL 199-204
44. Powers J.M., and Autopsy Committee of the College of American Pathologists. Practice guidelines for autopsy pathology: autopsy procedures for brain, spinal cord, and neuromuscular system. Arch Pathol Lab Med 119 (1995) 777-783
45. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47 (1996) 1113-1124
46. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease: the National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 18 Suppl (1997) S1-S2
47. Braak H., and Braak E. Neuropathologic stageing of Alzheimer related changes. Acta Neuropathol 82 (1991) 239-259
48. Tierney M.C., Fisher R.H., Lewis A.J., Zorzitto M.L., Snow W.G., Reid D.W., et al. The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 38 (1988) 359-364
49. Murayama S., and Saito Y. Neuropathologic diagnostic criteria for Alzheimer's disease. Neuropathology 24 (2004) 254-260
50. Nagi Z., Esiri M.M., Hindley N.J., Joachim C., Morris J.H., King E.M., et al. Accuracy of clinical operational diagnostic criteria for Alzheimer's disease in relation to different pathological diagnostic protocols. Dementia & Geriatric Cog Disord 9 (1998) 219-226
51. Newell K.L., Hyman B.T., Growdon J.H., and Hedley-White E.T. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol 58 (1999) 1147-1155
52. Zaccai J., Ince P., and Brayne C. Population-based neuropathological studies of dementia: design, methods and area of investigation: a systematic review. BMC Neurology 6 (2006) 2. http://www.biomedcentral.com/1471-2377/6/2 Available at: http://www.biomedcentral.com/1471-2377/6/2
53. Whyte S.R., Cullum C.M., Hynan L.S., Lacritz L.H., Rosenberg R.N., and Weiner M.F. Performance of elderly Native Americans and Caucasians on the CERAD Neuropsychological Battery. Alzheimer Dis Assoc Disord 19 (2005) 74-78
54. Aharon-Peretz J., Daskovski E., Mashiach T., Kliot D., and Tomer R. Progression of dementia associated with lacunar infarctions. Dementia & Geriatric Cog Disord 16 (2003) 71-77
55. Aharon-Peretz J., Daskovski E., Mashiach T., and Tomer R. Natural history of dementia associated with lacunar infarctions. J Neurol Sci 203-204 (2002) 53-55
56. Arango Lasprilla J.C., Iglesias J., and Lopera F. Neuropsychological study of familial Alzheimer's disease caused by mutation E280A in the presenilin 1 gene. Am J Alzheimer's Disease & Other Dementias 18 (2003) 137-146
57. Garcia-Ospina G.P., Jimenez-Del Rio M., Lopera F., and Velez-Pardo C. Neuronal DNA damage correlates with a positive detection of c-Jun, nuclear factor kB, p53 and Par-4 transcription factors in Alzheimer's disease. Revista de Neurologia 36 (2003) 1004-1010
58. Ganguli M., Chandra V., Gilby J., Ratcliff G., Sharma S.D., Pandav R., et al. Cognitive test performance in a community-based nondemented elderly sample in rural India: the Indo-U.S. Cross-National Dementia Epidemiology Study. Int Psychogeriatr 8 (1996) 507-524
59. Prince M., Acosta D., Chiu H., Scazufca M., Varghese M., and Dementia Research Group. Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet 361 (2003) 909-917
60. Barnhart R.L., van Belle G., Edland S.D., Kukull W., Borson S., Raskind M., et al. Geographically overlapping Alzheimer's Disease registries: comparisons and implications. J Geriatr Psychiatry Neurol 8 (1995) 203-208
61. Hughes J.P., van Belle G., Kukull W., Larson E.H., and Teri L. On the uses of registries for Alzheimer Disease. Alzheimer Dis Assoc Disord 3 (1989) 205-217
62. Huppert F.A., Brayne C., and O'Connor D.W. Dementia and normal aging (1994), Cambridge University Press, Cambridge, UK
63. Morris J.C. Mild cognitive impairment is early stage Alzheimer's disease: time to revise diagnostic criteria. Arch Neurol 63 (2006) 15-16
64. Heyman A, Fillenbaum G, Nash F, eds. Consortium to Establish a Registry for Alzheimer's Disease: the CERAD experience. Neurology 1997;49 (Suppl 3).
65. Morris J.C., Weintraub S., Chui H.C., Cummings J., DeCarli C., Ferris S., et al. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Alzheimer Dis Assoc Disord 20 (2006) 210-216
66. Fillenbaum G.G., Heyman A., Huber M.S., Woodbury M.A., Leiss J., Schmader K.E., et al. The prevalence and three-year incidence of dementia in older Black and White community residents. J Clin Epidemiol 51 (1998) 587-595
67. White L., Petrovitch H., Ross G.W., Masaki K.H., Abbott R.D., Teng E.L., et al. Prevalence of dementia in older Japanese-American men living in Hawaii: the Honolulu-Asia Aging Study. JAMA 276 (1996) 955-960
68. Obadia Y., Rotily M., Degrand-Guillaud A., Guelain J., Ceccaldi M., Severo C., et al. The PREMAP Study: prevalence and risk factors of dementia and clinically diagnosed Alzheimer's disease in Provence, France: prevalence of Alzheimer's disease in Provence. Eur J Epidemiol 13 (1997) 247-253
69. Plassman B.L., Langa K.M., Fischer G.G., Heeringa S.G., Weir D.R., Ofstedal M.B., et al. Prevalence of dementia in the United States: the Aging, Demographics, and Memory Study. Neuroepidemiology 29 (2007) 125-132
70. Breitner J.C.S., Wyse B.W., Anthony J.C., Welsh-Bohmer K.A., Steffens D.C., Norton M.C., et al. APOE-ε{lunate}4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology 53 (1999) 321-331
71. Miech R.A., Breitner J.C.S., Zandi P.P., Khachaturian A.S., Anthony J.C., and Mayer L. Incidence of AD may decline in the early 90s for men, later for women: the Cache County study. Neurology 58 (2002) 209-218
72. Tschanz J.T., Welsh-Bohmer K.A., Lyketsos C.G., Corcoran C., Green R.C., Hayden K., et al. Conversion to dementia from mild cognitive disorder: the Cache County Study. Neurology 67 (2006) 229-234
73. Bienias J.L., Beckett L.A., Bennett D.A., Wilson R.S., and Evans D.A. Design of the Chicago Health and Aging Project (CHAP). J Alzheimers Dis 5 (2003) 349-355
74. Breitner J.C., Welsh K.A., Gau B.A., McDonald W.M., Steffens D.C., Saunders A.M., et al. Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. Arch Neurol 52 (1995) 763-771
75. Plassman B.L., Steffens D.C., Burke J.R., Welsh-Bohmer K.A., Newman T.N., Drosdick D., et al. Duke twins study of memory in aging in the NAS-NRC Twin Registry. Twin Res Hum Gene 9 (2006) 950-957
76. Hendrie H.C., Osuntokun B.O., Hall K.S., Ogunniyi A.O., Hui S.L., Unverzagt F.W., et al. The prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am J Psychiatry 152 (1995) 1485-1492
77. Hendrie H.C., Ogunniyi A., Hall K.S., Baiyewu O., Unverzagt F.W., Gureje O., et al. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA 14 (2001) 285 739-47
78. Chandra V., Ganguli M., Pandav R., Johnston J., Belle S., and DeKosky S.T. Prevalence of Alzheimer's disease and other dementias in rural India: the Indo-US study. Neurology 51 (1998) 1000-1008
79. Graves A.B., Larson E.B., Edland S.D., Bowen J.D., McCormick W.C., McCurry S.M., et al. Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington State: the Kame Project. Am J Epidemiol 144 (1996) 760-771
80. Shin H.Y., Chung E.K., Rhee J.A., Yoon J.S., and Kim J.M. Prevalence and related factors of dementia in an urban elderly population using a new screening method. [Korean]. J Preventive Med Public Health / Yebang Uihakhoe Chi 38 (2005) 351-358
81. Ganguli M., Ratcliff G., Huff F.J., Belle S., Kancel J.J., Fischer L., et al. Effects of age, gender and education on cognitive tests in a rural elderly community sample: norms from the Monongahela Valley Independent Elders Survey. Neuroepidemiology 10 (1991) 42-52
82. Snowdon D.A., Kemper S.J., Mortimer J.A., Greiner L.H., Wekstein D.R., and Markesbery W.R. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life: findings from the Nun Study. JAMA 275 (1996) 528-532
83. Snowdon D.A. Aging and Alzheimer's disease: lessons from the Nun Study. Gerontologist 37 (1997) 150-156
84. Bennett D.A., Wilson R.S., Schneider J.A., Evans D.A., Beckett L.A., Aggarwal N.T., et al. Natural history of mild cognitive impairment in older persons. Neurology 59 (2002) 198-205
85. Bennett D.A., Schneider J.A., Buchman A.S., Mendes de Leon C.F., Bienias J.L., and Wilson R.S. The Rush Memory and Aging Project: study design and baseline characteristics of the study cohort. Neuroepidemiology 25 (2005) 163-175
86. Lin R.T., Lai C.L., Tai C.T., Liu C.K., Yen Y.Y., and Howng S.L. Prevalence and subtypes of dementia in southern Taiwan: impact of age, sex, education, and urbanization. J Int Neuropsychol Soc 160 (1998) 67-75
87. Plassman B.L., Havlik R.J., Steffens D.C., Helms M.J., Newman T.N., Drosdick D., et al. Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology 55 (2000) 1158-1166
88. Alafuzoff I., Pikkarainen M., Al-Sarraj S., Arzberger T., Bell J., Bodi I., et al. Interlaboratory comparison of assessments of Alzheimer disease-related lesions: a study of the BrainNet Europe Consortium. J Neuropathol Exp Neurol 65 (2006) 740-757
89. Jobst K.A., Barnetson L.P., and Shepstone B.J. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias-Oxford Project to Investigate Memory and Aging. Int Psychogeriatr 10 (1998) 271-302
90. Neuropathology Group of the U.K. Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357 (2001) 169-175
91. Tractenberg R.E., Gamst A., Thomas R.G., Patterson M., Schneider L.S., and Thal L.J. Investigating emergent symptomatology as an outcome measure in a behavioral study of Alzheimer's disease. J Neuropsychiatry Clin Neurosci 14 (2002) 303-310
92. Teri L., Logsdon R.G., Peskind E., Raskind M., Weiner M.F., Tractenberg R.E., et al. Treatment of agitation in AD: a randomized, placebo-controlled clinical trial. Neurology 55 (2000) 1271-1278 Erratum in Neurology 2001;56:426
93. Patterson M.B., Mack J.L., Mackell J.A., Thomas R., Tariot P., Weiner M., et al. A longitudinal study of behavioral pathology across five levels of dementia severity in Alzheimer's disease: the CERAD Behavior Rating Scale for Dementia-the Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 11 Suppl 2 (1997) S40-S44
94. Espeland M.A., Rapp S.R., Shumaker S.A., Brunner R., Manson J.E., Sherwin B.B., et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291 (2004) 2959-2968
95. Rapp S.R., Espeland M.A., Shumaker S.A., Henderson V.W., Brunner R.L., Manson J.E., et al. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (2003) 2663-2672
96. Shumaker S.A., Legault C., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study-a randomized controlled trial. JAMA 289 (2003) 2651-2662
97. Shumaker S.A., Legault C., Kuller L., Rapp S.R., Thal L., Lane D.S., et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291 (2004) 2947-2958
98. Kryscio R.J., Mendiondo M.S., Schmitt F.A., and Markesbery W.R. Designing a large prevention trial: statistical issues. Stat Med 23 (2004) 285-296
99. Mendiondo M.S., Ashford J.W., Kryscio R.J., and Schmitt F.A. Designing a brief Alzheimer screen. J Alzheimers Dis 5 (2003) 391-398
100. MacLennan A.H., Henderson V.W., Paine B.J., Mathias J., Ramsay E.N., Ryan P., et al. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study. Menopause 13 (2006) 28-36
101. Welsh K., Butters N., Hughes J.P., Mohs R.C., and Heyman A. Detection and staging of dementia in Alzheimer's disease: use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol 49 (1992) 448-452
102. Welsh K.A., Butters N., Mohs R.C., Beekly D., Edland S., Fillenbaum G., et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): part V-a normative study of the neuropsychological battery. Neurology 44 (1994) 609-614
103. Beeri M.S., Schmeidler J., Sano M., Wang J., Lally R., Grossman H., et al. Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old. Neurology 67 (2006) 1006-1010
104. Welsh K.A., Fillenbaum G., Wilkinson W., Heyman A., Mohs R.C., Stern Y., et al. Neuropsychological test performance in African-American and white patients with Alzheimer's disease. Neurology 45 (1995) 2207-2211
105. Fillenbaum G.G., Kuchibhatla M., Henderson V.W., Clark C.M., and Taussig I.M. Comparison of performance on the CERAD Neuropsychological Battery of Hispanic patients and cognitively normal controls at two sites. Clin Gerontologist 30 (2007) 1-22
106. Collie A., Shafiq-Antonacci R., Maruff P., Tyler P., and Currie J. Norms and the effects of demographic variables on a neuropsychological battery for use in healthy ageing Australian populations. Aust N Z J Psychiatry 33 (1999) 568-575
107. Bertolucci P.H.F., Okamoto I.H., Brucki S.M.D., Siviero M.O., Neto J.T., and Ramos L.R. Applicability of the CERAD Neuropsychological Battery to Brazilian elderly. Arq Neuropsiquiatr 59 (2001) 532-536
108. Karrasch M., and Laine M. Age, education and test performance on the Finnish CERAD. Acta Neurol Scand 108 (2003) 97-101
109. Karrasch M., Sinerva E., Gronholm P., Rinne J., and Laine M. CERAD test performances in amnestic mild cognitive impairment and Alzheimer's disease. Acta Neurol Scand 111 (2005) 172-179
110. Unverzagt F.W., Morgan O.S., Thesiger C.H., Eldemire D.A., Luseko J., Pokuri S., et al. Clinical utility of CERAD neuropsychological battery in elderly Jamaicans. J Int Neuropsychol Soc 5 (1999) 255-259
111. Lee D.Y., Lee K.U., Lee J.H., Kim K.W., Jhoo J.H., Kim S.Y., et al. A normative study of the CERAD neuropsychological assessment battery in the Korean elderly. J Int Neuropsychol Soc 10 (2004) 72-81
112. Guruje O., Unverzargt F.W., Osuntokun B.O., Hendrie H.C., Baiyewu O., Ogunniyi A., et al. The CERAD Neuropsychological Test Battery: norms from a Yoruba-speaking Nigerian sample. West African J Med 14 (1995) 29-33
113. Berres M., Monsch A.U., Bernasconi F., Thalmann B., and Stahelin H.B. Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease. Studies in Health Technology Information 77 (2000) 195-199
114. Stewart R., Richards M., Brayne C., and Mann A. Cognitive function in UK community-dwelling African Caribbean elders: normative data for a test battery. Int J Geriatric Psychiatry 16 (2001) 518-527
115. Unverzagt F.W., Hall K.S., Torke A.M., Rediger J.D., Mercado N., Gureje O., et al. Effects of age, education, and gender on CERAD neuropsychological test performance in an African-American sample. Clin Neuropsychol 10 (1996) 180-190
116. Fillenbaum G.G., McCurry S.M., Kuchibhatla M., Masaki K.H., Borenstein A.R., Foley D.J., et al. Performance on the CERAD neuropsychology battery of two samples of Japanese-American elders: norms for persons with and without dementia. J Int Neuropsychol Soc 11 (2005) 192-201
117. McCurry S.M., Gibbons L.E., Uomoto J.M., Thompson M.L., Graves A.B., Edland S.D., et al. Neuropsychological test performance in a cognitively intact sample of older Japanese American adults. Arch Clin Neuropsychol 16 (2001) 447-459